1. Alagille, D.; Estrada, A.; Hadchouel, M.; Gautier, M.; Odievre, M.; Dommergues, J.P. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): Review of 80 cases. J. Pediatr. 1987, 110 (2), 195-200.

2. Crosnier, C.; Lykavieris, P.; Meunier-Rotival, M.; Hadchouel, M. Alagille syndrome. The widening spectrum of arteriohepatic dysplasia. Clin. Liver Dis. 2000, 4 (4), 765-778.

3. Lykavieris, P.; Hadchouel, M.; Chardot, C.; Bernard, O. Outcome of liver disease in children with Alagille syndrome: A study of 163 patients. Gut 2001, 49 (3), 431-435.

4. Bernard, O.; Hadchouel, M. Pediatric Liver Disease. In Oxford Textbook of Clinical Hepatology; Bircher, J., Benahamou, J.P., McIntyre, N., Rizetto, M., Rodes, J., Eds.; Oxford University Press: Oxford, 1999; 1877-1889.

5. McElhinney, D.B.; Krantz, I.D.; Bason, L.; Piccoli, D.A.; Emerick, K.M.; Spinner, N.B.; Goldmuntz, E. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 2002, 106 (20), 2567-2574.

6. Brodsky, M.C.; Cunnif, C. Ocular anomalies in the Alagille syndrome (arteriohepatic dysplasia). Ophthalmology 1993, 100 (12), 1767-1774.

7. Hoffenberg, E.J.; Narkewicz, M.R.; Sondheimer, J.M.; Smith, D.J.; Silverman, A.; Sokol, R.J. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J. Pediatr. 1995, 127 (2), 220-224.

8. Emerick, K.M.; Rand, E.B.; Goldmuntz, E.; Krantz, I.D.; Spinner, N.B.; Piccoli, D.A. Features of Alagille syndrome in 92 patients: Frequency and relation to prognosis. Hepatology 1999, 29 (3), 822-829.

9. McDiarmid, S.V.; Vargas, J.H. Variable morbidity in Alagille syndrome: A review of 43 cases. J. Pediatr. Gastroenterol. Nutr. 1999, 29 (4), 431-437.

10. Lykavieris, P.; Crosnier, C.; Trichet, C.; Meunier-Rotival, M.; Hadchouel, M. Bleeding tendency in children with Alagille syndrome. Pediatrics 2003, 111 (1), 167-170.

11. Li, L.; Krantz, I.D.; Deng, Y.; Genin, A.; Banta, A.B.; Collins, C.C.; Qi, M.; Trask, B.J.; Kuo, W.L.; Cochran, J.; Costa, T.; Pierpont, M.E.; Rand, E.B.; Piccoli, D.A.; Hood, L.; Spinner, N.B. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 1997, 16 (3), 243 -251.

12. Oda, T.; Elkahloun, A.G.; Pike, B.L.; Okajima, K.; Krantz,

I.D.; Genin, A.; Piccoli, D.A.; Meltzer, P.S.; Spinner, N.B.; Collins, F.S.; Chandrasekharappa, S.C. Mutations in the human Jaggedl gene are responsible for Alagille syndrome. Nat. Genet. 1997, 16 (3), 235-242.

13. Ropke, A.; Kujat, A.; Graber, M.; Giannakudis, J.; Hansmann, I. Identification of 36 novel Jaggedl (JAG1) mutations in patients with Alagille syndrome. Human Mutat. 2003, 21 (1), 100.

14. Spinner, N.B.; Colliton, R.P.; Crosnier, C.; Krantz, I.D.; Hadchouel, M.; Meunier-Rotival, M. Jagged1 mutations in Alagille syndrome. Human Mutat. 2001, 17 (1), 18-33.

15. Crosnier, C.; Driancourt, C.; Raynaud, N.; Dhorne-Pollet, S.; Pollet, N.; Bernard, O.; Hadchouel, M.; Meunier-Rotival, M. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology 1999, 116 (5), 1141-1148.

16. Nickoloff, B.J.; Osborne, B.A.; Miele, L. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents. Oncogene 2003, 22 (42), 6598-6608.

17. Maillard, I.; He, Y.; Pear, W.S. From the yolk sac to the spleen: New roles for Notch in regulating hematopoiesis. Immunity 2003, 18 (5), 587-589. ^

18. Crosnier, C.; Attie-Bitach, T.; Encha-Razavi, F.; Audollent, S.; Soudy, F.; Hadchouel, M.; Meunier-Rotival, M.; Vekemans, M. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 2000, 32 (3), 574581.

19. Hukriede, N.A.; Gu, Y.; Fleming, R.J. A dominantnegative form of Serrate acts as a general antagonist of Notch activation. Development 1997, 124 (17), 34273437.

20. Frischmeyer, P.A.; Dietz, H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 1999, 8 (10), 1893-1900.

21. McCright, B.; Lozier, J.; Gridley, T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129 (4), 10751082.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook

Post a comment